Biogen Inc. (LON:0R1B)
London
· Delayed Price · Currency is GBP · Price in USD 135.73
-0.59 (-0.43%)
At close: Feb 19, 2025
Biogen Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 18, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,285 | 17,799 | 29,437 | 33,096 | 26,027 | 27,598 | Upgrade
|
| Market Cap Growth | -39.53% | -39.53% | -11.06% | 27.16% | -5.69% | -31.73% | Upgrade
|
| Enterprise Value | 19,719 | 21,755 | 33,694 | 33,805 | 29,090 | 29,964 | Upgrade
|
| Last Close Price | 110.44 | 121.22 | 258.40 | 273.09 | 242.15 | 242.20 | Upgrade
|
| PE Ratio | 12.49 | 13.65 | 32.29 | 13.09 | 22.65 | 9.42 | Upgrade
|
| PS Ratio | 2.30 | 2.30 | 3.81 | 3.92 | 3.21 | 2.80 | Upgrade
|
| PB Ratio | 1.33 | 1.33 | 2.53 | 2.98 | 3.22 | 3.53 | Upgrade
|
| P/TBV Ratio | 40.82 | 40.82 | 172.63 | 6.88 | 12.10 | 20.32 | Upgrade
|
| P/FCF Ratio | 8.19 | 8.19 | 29.52 | 34.86 | 10.42 | 9.90 | Upgrade
|
| P/OCF Ratio | 7.75 | 7.75 | 24.23 | 28.81 | 9.68 | 8.91 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.81 | 4.36 | 4.00 | 3.59 | 3.04 | Upgrade
|
| EV/EBITDA Ratio | 7.99 | 9.09 | 18.06 | 11.52 | 10.04 | 8.01 | Upgrade
|
| EV/EBIT Ratio | 10.73 | 11.73 | 22.80 | 13.49 | 11.46 | 8.80 | Upgrade
|
| EV/FCF Ratio | 9.07 | 10.01 | 33.79 | 35.60 | 11.65 | 10.75 | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.40 | 0.50 | 0.50 | 0.70 | 0.74 | Upgrade
|
| Debt / EBITDA Ratio | 2.15 | 2.15 | 2.95 | 1.85 | 1.91 | 1.52 | Upgrade
|
| Debt / FCF Ratio | 2.47 | 2.47 | 5.85 | 5.87 | 2.27 | 2.08 | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.38 | 0.42 | 0.45 | 0.52 | Upgrade
|
| Inventory Turnover | 0.93 | 0.93 | 1.31 | 1.69 | 1.74 | 1.93 | Upgrade
|
| Quick Ratio | 0.77 | 0.77 | 1.04 | 2.39 | 1.34 | 1.32 | Upgrade
|
| Current Ratio | 1.35 | 1.35 | 2.00 | 2.99 | 1.83 | 1.84 | Upgrade
|
| Return on Equity (ROE) | 10.36% | 10.36% | 8.24% | 24.33% | 15.96% | 33.80% | Upgrade
|
| Return on Assets (ROA) | 5.29% | 5.29% | 4.58% | 7.79% | 8.86% | 11.21% | Upgrade
|
| Return on Capital (ROIC) | 6.36% | 6.36% | 5.56% | 9.74% | 11.53% | 15.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.31% | 10.31% | 8.04% | 14.18% | 17.55% | 22.28% | Upgrade
|
| Earnings Yield | 8.01% | 7.32% | 3.10% | 7.64% | 4.42% | 10.62% | Upgrade
|
| FCF Yield | 13.35% | 12.21% | 3.39% | 2.87% | 9.60% | 10.10% | Upgrade
|
| Buyback Yield / Dilution | -0.21% | -0.21% | 0.27% | 2.41% | 7.25% | 13.93% | Upgrade
|
| Total Shareholder Return | -0.21% | -0.21% | 0.27% | 2.41% | 7.25% | 13.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.